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Background: The Severe Respiratory Insufficiency (SRI) questionnaire is a specific measure of health-related quality
of life (HRQoL) in patients treated with long-term mechanical ventilation (LTMV). The aim of the present study was
to examine whether SRI sum scores and related subscales are associated with mortality in LTMV patients.
Methods: The study included 112 LTMV patients (non-invasive and invasive) from the Norwegian LTMV registry in
Western Norway from 2008 with follow-up in August 2014. SRI data were obtained through a postal questionnaire,
whereas mortality data were obtained from the Norwegian Cause of Death Registry. The SRI questionnaire contains 49
items and seven subscales added into a summary score (range 0–100) with higher scores indicating a better HRQoL.
The association between the SRI score and mortality was estimated as hazard ratios (HRs) with 95% confidence
intervals (95% CI) using Cox regression models and HRs were estimated per one unit change in the SRI score.
Results: Of the 112 participating patients in 2008, 52 (46%) had died by August 2014. The mortality rate was the
highest in patients with chronic obstructive pulmonary disease (75%), followed by patients with neuromuscular disease
(46%), obesity hypoventilation syndrome (31%) and chest wall disease (25%) (p < 0.001). Higher SRI sum scores in 2008
were associated with a lower mortality risk after adjustment for age, education, hours a day on LTMV, time since
initiation of LTMV, disease category and comorbidity (HR 0.98, 95% CI: 0.96–0.99). In addition, SRI-Physical Functioning
(HR 0.98, 95% CI: 0.96–0.99), SRI-Psychological Well-Being (HR 0.98, 95% CI: 0.97–0.99), and SRI-Social Functioning (HR 0.
98, 95% CI: 0.97–0.99) remained significant risk factors for mortality after covariate adjustment. In the subgroup analyses
of patient with neuromuscular diseases we found significant inverse associations between some of the SRI subscales
and mortality.
Conclusions: SRI score is associated with mortality in LTMV-treated patients. We propose the use of SRI in the daily
clinic with repeated measurements as part of individual follow-up. Randomized clinical trials with interventions aimed
to improve HRQoL in LTMV patients should consider the SRI questionnaire as the standard HRQoL measurement.
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Chronic hypercapnic respiratory failure (CHRF) is a
persistent state in which ventilation is insufficient to main-
tain a normal arterial pressure of carbon dioxide (PaCO2)
[1, 2]. Long-term mechanical ventilation (LTMV) is a
treatment for patients with CHRF due to different aetiol-
ogies and includes both non-invasive and invasive mech-
anical ventilation [2–4]. In adults, CHRF is mainly caused
by the following four disease categories: neuromuscular
diseases (NMD), chest wall diseases (CWD), obesity
hypoventilation syndrome (OHS), and chronic obstructive
pulmonary disease (COPD) [2–4]. The number of individ-
uals treated with LTMV is increasing, and the largest
growth has been observed in the use of a non-invasive
connection to the ventilator through a mask or a mouth-
piece [2, 3]. One of the main goals of LTMV is to improve
survival [2, 4]. Due to ethical reasons, few randomized
controlled trials (RCTs) comparing LTMV versus no
LTMV treatment have been carried out in these patients
[2, 3]. One of the exceptions is RCTs involving COPD pa-
tients with CHRF, where the benefit of LTMV on survival
has been and continues to be debated [3, 5, 6]. Two recent
RCTs found improved one-year mortality in COPD pa-
tients treated with non-invasive LTMV [7, 8]. In NMD pa-
tients LTMV has been well-established for several decades
[2–4]. One of the few RCTs in this heterogenic category
found improved mortality in patients with amyotrophic
lateral sclerosis (ALS) [9].
Additionally, several observational studies and
uncontrolled trials indicated that LTMV has a positive
effect on survival in patients with NMD [10–16],
OHS [10, 13, 17–20] and CWD [10–13, 21–23] rela-
tive to historical controls.
Self-reported health or health-related quality of life
(HRQoL) has been shown to provide prognostic infor-
mation for different groups [11, 24–27]. The Severe
Respiratory Insufficiency (SRI) questionnaire was devel-
oped to specifically measure patient-reported HRQoL in
patients receiving LTMV [28]. The role of SRI in pre-
dicting mortality in patients with CHRF has been exam-
ined during two three-year follow-up studies [29, 30]. In
the first study, the clinical variables body mass index
(BMI), leukocytes, base excess, forced expiratory volume
in one second (FEV1), and inspiratory vital capacity were
included in the multivariate analysis [29]. The SRI score
was associated with mortality in all patients except for
those with COPD [29]. The second study found signifi-
cant relationships between the SRI score and three-year
mortality in LTMV patients with COPD and pulmonary
tuberculosis sequelae after adjustment for BMI, PaCO2
and forced vital capacity (FVC), but without subgroup
analyses for the different diagnosis group [30]. Other
measures of HRQoL, such as St. George’s Respiratory
Questionnaire (SGRQ) and the Maugeri RespiratoryFailure Questionnaire (MRF-28), were associated with
mortality in LTMV-treated COPD patients from 21
study centres during 3 years of follow-up [26]. The SRI
score’s ability to predict mortality in patients treated
with LTMV has been poorly investigated. Furthermore,
findings are inconclusive [29, 30] and the associations
have been investigated for only a limited time period (up
to three years). Longer follow-up time might capture a
more robust association due to higher mortality rates
over time.
Methods
The main objective of the current study was to examine
the association between HRQoL measured by the SRI
questionnaire and all-cause mortality in LTMV patients
over 80 months follow-up.
Study population
This study drew on resources from the Norwegian
Registry for LTMV [31], the Norwegian Patient Registry
[32], and the Norwegian Cause of Death Registry [33].
The registry data were linked by the personal identity
number provided to all Norwegian citizens. The study
was approved by the Regional Committee for Medical
and Health Research Ethics number (273.06, 2012/
1090–11) and the Norwegian Centre for Research Data
(project number 16001). A written consent was a pre-
requisite from the Regional Committee for Medical and
Health Research Ethics and the NPR to allow linking
data between the registries. For cohort patients who
died, exemption from the consent requirement for regis-
ter connection to the Norwegian Patient Registry and
Cause of Death Register was given.
The Norwegian Registry for LTMV was established in
2002 at Haukeland University Hospital, Bergen. The
registry includes all patients in Norway who are treated
with LTMV on a daily basis. The registry contains
detailed information on patient characteristics, medical
diagnosis, LTMV treatment and lung function. The
registry has been described in detail previously [34, 35].
During the period of March to June 2008, patients in
the Norwegian LTMV registry in Western Norway were
invited to participate in the current study. The inclusion
criteria were patients treated with non-invasive or inva-
sive LTMV, over 18 years old and mentally able to an-
swer additional study questions. Well-adapted LTMV
treatment for at least 3 months was required for all par-
ticipants. The invitation letter also included the SRI
questionnaire, a form with questions on socioeconomic
demographic conditions, and questions whether the pa-
tient had received help with completing the information.
Of 211 potential patients in the LTMV registry, 18
patients did not meet the inclusion criteria (Fig. 1). The
remaining 193 eligible patients were invited to participate
Fig. 1 Flow diagram of patients treated with long-term mechanical ventilation in the prospective cohort study from 2008 to 2014. Follow-up time
was 80months
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to participate [34]. Of the 127 patients eligible for
follow-up, written consent to connect comorbidity data
from the NPR were not available from 15 of the patients.
The reason for this were dementia or unable to answer
the question (n = 3), had stopped using LTMV (n = 8),
unable to make contact (n = 1) or did not want to respond
(n = 3). The disease category for these patients were NMD
(n = 6), COPD (n = 2), OHS (n = 6) and CWD (n = 1),
leaving a final study sample of 112 LTMV patients.
The severe respiratory insufficiency (SRI) questionnaire
Study participants were asked to complete the SRI ques-
tionnaire, which is a multidimensional questionnaire
covering physical, psychological and social functioning.
It was developed with a comprehensive methodology by
physicians specialized in pulmonology and psychologists
specialized in HRQoL and by open interviews with pa-
tients with CHRF treated with LTMV. The SRI question-
naire contains 49 items, and each item is categorized in
one of the following seven subscales: SRI-Respiratory
Complaints, SRI-Physical Functioning, SRI-Attendant
Symptoms and sleep, SRI-Anxiety, SRI-Social Relation-
ships, SRI-Social Functioning, or SRI-Psychological
Well-Being. The subscales were added into a summary
scale in which high values (range 0–100) indicate a bet-
ter HRQoL [28]. The SRI questionnaire demonstrates
very good psychometric qualities and has been validated
and translated into several languages [2, 34–40]. TheSRI and MRF-28 questionnaires were recommended for
research on HRQoL in patients treated with LTMV [41].
However, the reliability and validity in were better in the
SRI compared to MRF-28 Questionnaire, Clinical COPD
Questionnaire and Chronic Respiratory Questionnaire in
patients with severe COPD treated with non-invasive
LTMV [42]. The responsiveness of the SRI to changes in
HRQoL after initiating non-invasive LTMV was superior
to the generic questionnaire Short form-36 [43] and the
SRI had the best ability to predict mortality compared to
other HRQoL questionnaires [30]. The English valid-
ation study of the SRI included both non-invasive and
invasive (tracheostomy) ventilated LTMV patients [37].
All-cause mortality
Information on the date of death was obtained from the
Norwegian Cause of Death Registry in October 2014.
The Cause of Death Registry covers all deaths in Norway
and the deaths of Norwegian citizens who die abroad
[33]. All deaths (approximately 40,000 each year) are
reported by doctors, who are required to complete a
standardized death certificate for each death [33].
Other variables
Based on previous research we also obtained data on
educational level [44] and marital status [45]. Educational
level was categorized as primary school, high school or
college/university, and marital status was classified as mar-
ried/cohabiting or single/divorced/widowed. Ventilator
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they used the ventilator, the answer options were catego-
rized as follow; less than 8 h, 8–12, 12–24 h a day.
From the LTMV registry, we collected data on patient
age, sex, treatment time since initiation of LTMV, FVC,
FEV1, PaCO2, partial pressure of arterial oxygen (PaO2)
and main medical diagnosis, which was further catego-
rized into NMD, COPD, OHS, and CWD. Studies have
shown that comorbidity is a major prognostic factor in
LTMV patients with NMD [13], COPD [46], OHS [18]
and CWD [22]. Data concerning comorbidity were not
available in the LTMV registry and were therefore col-
lected from the Norwegian Patient Registry (NPR) [33],
In this study, comorbidity was assessed similar to an-
other study [47], as the number of somatic ICD-10 diag-
nosis codes at hospital discharge or an outpatient
control for each patient during the recruitment period
from March to June 2008.
Statistical analysis
Patient characteristics were quantified using descrip-
tive statistics. The description was performed ac-
cording to mean SRI sum score and to mortality
status. We used the Kaplan-Meier survivor function
with the log-rank test to describe the percentage of
survivors according to disease groups (NMD, COPD,
OHS and CWD).
The association between SRI and mortality was esti-
mated as hazard ratios (HRs) with 95% confidence inter-
vals (95% CIs) using Cox regression models and HRs
were estimated per one unit change in the SRI score.
The time in months from study inclusion in 2008 (when
baseline SRI was measured) until death was used as a
measure of event-free time. All patients were followed
up to 80months until censoring, with August 30, 2014,
as the final day of follow-up. We verified that the pro-
portional hazards assumption was fulfilled for SRI, both
in overall analyses and in subgroup analyses of NMD,
COPD and OHS, by visual inspection of log-log plots.
Subgroup analyses of CWD were not performed due to
the small sample size.
The HRs with 95% CIs were estimated both by crude
and adjusted Cox regression models to control for vari-
ables that may potentially confound the true association
between SRI and mortality. The adjustment variables
included age, education, hours a day on LTMV, treat-
ment time since initiation of LTMV, main disease
category and comorbidity. We also evaluated FEV1 and
FVC as confounding factors in the overall analyses of
SRI. To avoid model overfitting in subgroup analysis of
disease categories, only the most important covariates
were included in the regression models (for NMD: age,
hours a day on LTMV, and comorbidity; for COPD: age
and comorbidity; for OHS: comorbidity only).All statistical analyses were carried out using SPSS
version 20 (SPSS Inc., Chicago, IL, USA) and Stata
SE 14 (StataCorp LP, College Station, TX, USA) for
Windows. All statistical tests were two-sided, and p




The study sample comprised 112 LTMV-treated pa-
tients. Of these patients, 48 (43%) were diagnosed with
NMD, 24 (21%) with COPD, 32 (29%) with OHS, and 8
(7%) with CWD. At baseline, 103 (92%) patients received
non-invasive LTMV, whereas 9 (8%) patients, with
NMD, were ventilated invasively via tracheostomy. The
mean BMI (n = 71) was 27.1 (9.5) in NMD patients, 29.2
(9.1) in COPD patients, 40.6 (7.7) in OHS patients, and
22.5 (5.1) kg/m2 in CWD patients.
The baseline mean SRI sum score varied considerably
by sex, age group, education level, LTMV hours a day,
years on LTMV, disease category and comorbidity
(Table 1). The SRI sum score in invasively (n = 10) and
non-invasively (n = 117) ventilated patients was 57.0 (16.2)
and 58.0 (18.8), respectively. Assistance to complete the
SRI questionnaire was reported by 26% of the study
participants.
Among the respiratory variables, baseline FEV1 and
FVC correlated significantly with all SRI subscales ex-
cept for SRI-Attendant symptoms and sleep scale and
SRI-Social Functioning (Additional file 1: Table S1).
Baseline PaO2 correlated significantly with SRI-Physical
Functioning only. All participants were receiving ventila-
tion treatment at study start, and PaCO2 levels were
therefore normalized at baseline. An inverse correlation
between baseline PaCO2 and SRI-Social Relationships
was present, but no other associations were found for
the SRI sum score or for any of the six remaining SRI
subscales (Additional file 1: Table S1).
During the 80 months of follow-up, 52 (46%) patients
died (Fig. 1). By Kaplan-Meier survival analyses (Fig. 2),
we found that patients with COPD had the highest over-
all mortality rate (75%), followed by patients with NMD
(46%), OHS (31%) and CWD (25%) (p < 0.001) (Fig. 2).
The mortality rates differed between age groups, educa-
tion levels, LTMV hours a day, years on LTMV, disease
categories and burden of comorbidity (Table 2), but not
between men and women (p = 0.88), and between mar-
ried /cohabiting and single/divorced/widowed (p = 0.91).
We found significant differences between survivors and
deceased patients in baseline mean FEV1 and FVC (both
p < 0.001), and a minor difference in PaO2 that was not
statistically significant (Table 2). There was no signifi-
cant difference in PaCO2 between the survivors and
deceased patients (Table 2).
Table 1 Baseline sum score of the Severe Respiratory Insufficiency
questionnaire by background characteristics in 112 patients treated







Female 48 51.4 (16.7)
Male 57 57.7 (19.5)
Age
≤ 60 37 59.0 (16.7)
> 60 68 52.5 (19.2)
Education
Primary school 31 50.0 (20.5)
High school 41 52.2 (16.0)
College/university 33 62.5 (17.6)
Marital status
Married /cohabiting 60 54.7 (19.1)
Single/divorced/widowed 45 54.9 (18.0)
LTMV h/day
5–8 45 57.9 (18.3)
8–12 42 55.2 (18.8)
12–24 16 44.9 (17.1)
Years on LTMV
≤ 4 60 51.9 (18.2)
> 4 45 58.6 (18.4)
Disease
NMD 43 60.0 (14.8)
COPD 23 41.1 (18.3)
OHS 31 58.0 (18.5)
CWD 8 54.3 (21.1)
Co-morbidity
No additionally diagnosis 41 60.2 (17.6)
1 additionally diagnosis 28 55.7 (17.9)
≥ 2 additionally diagnosis 36 48.0 (18.3)
Abbreviations: SRI-SS, Severe Respiratory Insufficiency sum score; SD, standard
deviation; CI, confidence interval; LTMV, long-term mechanical ventilation;
NMD, neuro muscular disease; COPD, chronic obstructive pulmonary disease;
OHS, obesity hypoventilation syndrome; CWD, chest wall diseasese
a Numbers do not add to 112 due to missing in the Severe Respiratory
Insufficiency questionnaire, as well as missing in education level, marital status
and daily hours on LTMV responses
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Crude analyses of baseline SRI showed significantly higher
mean values among the survivors compared to the de-
ceased for the SRI sum score and SRI subscales except in
the SRI-Attendant symptoms and sleep scale (Table 3).
The association between the SRI sum score and mor-
tality remained significant after adjustment for age, edu-
cation level, hours a day on LTMV, treatment time sinceinitiation of LTMV, disease category and comorbidity
(HR 0.98, 95% CI: 0.96–0.99). In addition, SRI-Physical
Functioning (HR 0.98, 95% CI: 0.96–0.99),
SRI-Psychological Well-Being (HR 0.98, 95% CI: 0.97–
0.99), and SRI-Social Functioning (HR 0.98, 95% CI:
0.97–0.99) remained significant risk factors for mortality
after covariate adjustment (Table 4). Additional adjust-
ment for baseline FVC and FEV1 did not alter the results
much for SRI sum score (adjustment for FVC: HR 0.97,
95% CI: 0.94, 0.99); adjustment for FEV1: HR 0.97, 95%
CI 0.94, 0.99).
Among NMD patients, SRI-Physical Functioning (HR
0.97, 95% CI: 0.94–1.00), SRI-Psychological Well-Being
(HR 0.97, 95% CI: 0.95–0.99) and SRI-Social Functioning
(HR 0.97, 95% CI: 0.94–0.99) remained significant
factors for mortality after adjustment for age, hours a
day on LTMV and comorbidity (Table 5).
In COPD patients, SRI-Attendant Symptoms and Sleep
(HR 0.97, 95% CI: 0.94–1.00) and SRI-Psychological
Well-Being (HR 0.98, 95% CI: 0.96–1.00) remained associ-
ated with mortality after adjustment for age and comor-
bidity (Table 6). The SRI sum score or subscales were not
associated with mortality among patients with OHS (Add-
itional file 1: Table S2).
Discussion
We found that HRQoL, as measured by the SRI question-
naire, was inversely associated with mortality in LTMV
patients before and after adjustment for covariates. In the
total group of LTMV patients, the adjusted analyses showed
significant inverse associations between mortality and the
SRI sum score and the SRI subscales, ‘physical functioning’,
‘social functioning’ and ‘psychological well-being’. Further-
more, mortality varied considerably between the disease
groups during the six-year period. The highest mortality
was among COPD patients with established CHRF receiv-
ing LTMV. The majority of mortality in COPD is related to
cardiac disease and the requirement of LTMV in COPD
might be understood as a marker of overall frailty and
multi-system disease severity. The lowest mortality was in
the CWD group, reflecting the non-progressive nature of
the disease in these patients.
As shown in previous studies [3, 10–13, 23], mortality
in patients treated with LTMV is associated with under-
lying disease categories. Previous studies have shown large
variations in the attending patient categories, severity of
disease, and follow-up times. Thus, a direct comparison of
mortality between studies on patients with LTMV is
challenging and might lead to an oversimplification.
HRQoL as a prognostic factor
The association between poor HRQoL and increased
mortality in the total group of LTMV patients is consist-
ent with the main findings of other similar studies on
Fig. 2 Kaplan-Meier survival estimates in patients treated with long-term mechanical ventilation between 2008 and 2014. Follow-up time was 80
months. Abbreviations: NMD, neuro muscular disease; COPD, chronic obstructive pulmonary disease; OHS, obesity hypoventilation syndrome;
CWD, chest wall diseasese
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crude analyses of SRI were significantly associated with
mortality in all SRI subscales, with the exception of the
‘attendant symptoms and sleep’ scale.
The adjusted analyses among NMD patients showed
that SRI ‘physical functioning’, ‘psychological well-being’
and ‘social functioning’ continued to be significant factors
for mortality, which was consistent with the study by
Budweiser [30], but with different adjustment variables
than those in our study. We also found associations
between SRI and mortality among COPD patients in the
adjusted analyses in the ‘attendant symptoms and sleep’
and ‘psychological well-being’ SRI subscales.
The initial choice of the adjustment variables in the
present study was based on previous work that evaluated
age [10, 15, 26, 45], sex [18, 48], education level [44], mari-
tal status [45], disease categories (NMD, COPD, OHS and
CWD) [2, 3, 10–13, 23] and comorbidity [13, 18, 22, 46].
The variables ventilator dependency and time since LTMV
was initiated were chosen a priori. Marital status was not
associated with neither mortality nor the SRI sum score
and was therefore excluded as adjustment variable.
There were no sex differences between survivors and
those who deceased, thus sex also was excluded as an
adjustment variable.
However, we have considered the possibility that
HRQoL could be influenced by other confounding
covariates that might also pose a risk of death, such as
PaCO2. Reduced PaCO2 levels have been related to
lower one-year mortality and improved SRI scores in
COPD patients treated with LTMV [7, 8]. On the otherhand, exploratory analyses did not identify any signifi-
cant correlations between changes in hypercapnia status
or baseline hypercapnia status and mortality in this group
[5]. However, in the present study, PaCO2 values were
normalized at baseline as a result of ongoing LTMV and
were therefore not included in the analyses. The results
from studies on lung function and survival in LTMV pa-
tients are not conclusive. Some studies [19, 23, 30] re-
ported associations between low FEV1 and FVC and
mortality, whereas another study [11] found no differences
in baseline lung function between the survivors and de-
ceased patients. When FVC and FEV1 were added to the
Cox regression analysis in the current study, the result
was altered only slightly; however, this result might also be
influenced by missing lung function data (FVC baseline
numbers did not sum to 112 due to 23 missing data
points, FEV1 baseline numbers did not sum to 112 due to
22 missing data points), some of the missing data might
be explained due to patients having difficulties performing
the spirometry test.
We also considered to include ventilation mode as a
covariate as longer survival were reported in patients
with DMD using non-invasive LTMV compared to those
receiving LTMV via a tracheostomy [14, 49]. However,
another study concluded that the risk of death was not
associated with use of invasive versus non-invasive
LTMV in patients with DMD [16], No significant differ-
ence in one year mortality was found between patients
receiving LTMV via a tracheostomy and those weaned
after discharged from the Intensive Care Unit (ICU) and
no significant difference in HRQoL measured by SRI at
Table 2 Background variables at baseline in the survivors and deceased individuals treated with LTMV between 2008 and 2014
Characteristic All participants, n (n = 112) Survivors, n (%) (n = 60) Deceased, n (%) (n = 52)
Sex
Female 53 28 (53) 25 (47)
Male 59 32 (54) 27 (46)
Age
≤ 60 38 26 (68) 12 (32)
> 60 74 34 (46) 40 (54)
Education
Primary school 33 18 (55) 15 (45)
High school 44 23 (52) 21 (48)
College/university 35 19 (54) 16 (46)
Marital status
Married /cohabiting 64 34 (53) 30 (47)
Single/divorced/widowed 48 26 (54) 22 (46)
LTMV h/daya
5–8 50 33 (66) 17 (34)
8–12 42 23 (55) 19 (45)
12–24 17 2 (12) 15 (88)
Years on LTMV
≤ 4 65 33 (51) 32 (49)
> 4 47 27 (57) 20 (43)
Disease
NMD 48 26 (54) 22 (46)
COPD 24 6 (25) 18 (75)
OHS 32 22 (69) 10 (31)
CWD 8 6 (75) 2 (25)
Co-morbidity
No additionally diagnosis 44 32 (73) 12 (27)
1 additionally diagnosis 29 18 (62) 11 (38)
≥ 2 additionally diagnosis 39 10 (26) 29 (74)
Respiratorya
FVC (litre) (mean, SD) 89 2.64 (1.15) 1.89 (0.93)
FEV1(litre) (mean, SD) 90 1.88 (1.04) 1.16 (0.70)
PaCO2 kPa daytime (mean, SD) 84 5.61 (0.76) 6.01 (1.06)
PaO2 kPa daytime (mean, SD) 69 10.1 (1.78) 9.14 (1.92)
Abbreviations: LTMV, long-term mechanical ventilation; NMD, neuro muscular disease; COPD, chronic obstructive pulmonary disease; OHS, obesity hypoventilation
syndrome; CWD, chest wall disorders; FVC, forced vital capacity; FEV1, forced expiratory volume in one second; PaCO2, partial pressure of arterial carbon dioxide;
PaO2, partial pressure of arterial oxygen
a Numbers do not add to 112 due to missing in daily hours on LTMV and respiratory variables
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[50]. However, HRQoL tended to be lower, in the SRI
‘physical functioning’, while scores for ‘anxieties’ tended to
be better in patients receiving LTMV via tracheostomy
compared to those treated with non-invasive LTMV [51].
Although the analyses in the present study were ad-
justed for education level, other economic confounding
variables, such as income, might also have an impact onHRQoL and mortality. On the other hand, Norwegian
society and health care services probably represent one
of the most equitable systems worldwide, where all
citizens have equal access to health care services. Never-
theless, the number of covariates that could be included
in the analyses in this study was limited by the sample
size at baseline, and we can never exhaustively cover all
variables of minor importance among LTMV patients.
Table 3 Mean baseline scores (both sum score and subscales) of the Severe Respiratory Insufficiency questionnaire in patients
treated with long-term mechanical ventilation between 2008 and 2014
SRI Survivors (n = 60) Deceased (n = 52) P
valuebna mean (SD) na mean (SD)
SRI- Sum Score (SS) 58 60.0 (18.3) 47 48.4 (16.8) 0.001
SRI- Physical Functioning (PF) 59 45.9 (23.0) 50 26.9 (21.3) < 0.001
SRI- Respiratory Complaints (RC) 59 61.0 (22.4) 50 51.1 (22.6) 0.02
SRI- Attendant Symptoms and Sleep (AS) 59 53.3 (20.1) 50 55.8 (20.2) 0.53
SRI- Social Relationships (SR) 59 70.7 (24.4) 49 59.0 (21.8) 0.01
SRI- Anxiety (AX) 59 64.2 (27.5) 49 52.9 (27.2) 0.03
SRI- Psychological Well-Being (WB) 58 66.2 (22.0) 47 52.3 (22.9) 0.002
SRI- Social Functioning (SF) 59 56.5 (24.6) 49 39.1 (18.7) < 0.001
Abbreviations: SRI, Severe Respiratory Insufficiency; SD, standard deviation
a Numbers do not add to 60 and 52 due to missing in the Severe Respiratory Insufficiency questionnaire
b By two-sample t-test
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Previous studies using patient-reported measures other
than SRI have also reported an association between
self-reported health and mortality in patients treated
with LTMV [11, 26]. However, these studies did not
adjust for the same covariates as the present study, and
they lacked important variables, such as comorbidity
and education level. There is a large body of evidence on
the association between self-reported health measures
and mortality in other settings and disorders, such as in
communities [24], in patients with cancer [25] and idio-
pathic pulmonary fibrosis [27]. Explanations of these
consistent findings are complex and imply that survey
respondents’ perceptions of health status are holistic;
they include information on medical status but that
information might be evaluated differently by men and
women in different social positions, with different refer-
ence groups providing different social comparisons [24].
Further, the accuracy of self-reported health as a pre-
dictor of mortality depends on the comprehensivenessTable 4 Hazard ratios for mortality by baseline scores (both sum sco
questionnaire in all patients (n = 112) treated with long-term mecha
SRI Crude
N b HR 9
SRI- Sum Score (SS) 103 0.97 (0
SRI- Physical Functioning (PF) 107 0.97 (0
SRI- Respiratory Complaints (RC) 107 0.98 (0
SRI- Attendant Symptoms and Sleep (AS) 107 1.00 (0
SRI- Social Relationships (SR) 106 0.98 (0
SRI- Anxiety (AX) 106 0.99 (0
SRI- Psychological Well-Being (WB) 103 0.98 (0
SRI- Social Functioning (SF) 106 0.97 (0
Abbreviations: SRI Severe Respiratory Insufficiency, HR hazard ratio, CI confidence in
a Adjusted for age, education level, daily hours on LTMV, treatment time since initia
b Numbers do not add to 112 due to missing in the Severe Respiratory Insufficiencyand accuracy of the information that the person incor-
porates into the self-rating [52]. This hypothesis corre-
sponds with SRI as a multidimensional comprehensive
questionnaire that captures the symptoms of CHRF and
covers essential aspects of LTMV patients’ daily life [28].
Clinical implication of the associations between SRI and
mortality
Individuals suffering from CHRF treated with LTMV often
have an incurable disease [2–4]. Health care professionals
and relatives tend to behave differently depending on
whether the disease is perceived as a chronic or terminal
condition. However, the distinction between the patient’s
condition as chronic or terminal might become vague and
can sometimes be ambiguous and difficult to interpret
[53]. Prognostic information from the SRI questionnaire
might provide valuable knowledge on how to cope with
these situations, improving treatment plans and commu-
nication between involved professionals, family members,
and the LTMV patient. Our study demonstrates that there and subscales) of the Severe Respiratory Insufficiency
nical ventilation between 2008 and 2014
Adjusteda
5% CI P value HR 95% CI P value
.95, 0.98) 0.001 0.98 (0.96, 0.99) 0.04
.95, 0.98) < 0.001 0.98 (0.96, 0.99) 0.007
.97, 0.99) 0.01 0.99 (0.98, 1.01) 0.28
.99, 1.02) 0.50 0.99 (0.98, 1.01) 0.64
.97, 0.99) 0.009 0.99 (0.98, 1.00) 0.14
.99, 1.00) 0.03 0.99 (0.98, 1.00) 0.25
.97, 0.99) 0.001 0.98 (0.97, 0.99) 0.009
.96, 0.99) < 0.001 0.98 (0.97, 0.99) 0.02
terval
tion of LTMV, disease category and comorbidity
questionnaire
Table 5 Hazard ratios for mortality by baseline scores (both sum score and sub-scales) of the Severe Respiratory Insufficiency
questionnaire in neuromuscular patients (n = 48) treated with long-term mechanical ventilation between 2008 and 2014
SRI Crude Adjusteda
Nb HR 95% CI P value HR 95% CI P value
SRI- Sum Score (SS) 43 0.97 (0.94, 1.00) 0.09 0.97 (0.93, 1.01) 0.16
SRI- Physical Functioning (PF) 46 0.97 (0.94, 0.99) 0.008 0.97 (0.95, 1.00) 0.05
SRI- Respiratory Complaints (RC) 45 1.00 (0.98, 1.02) 0.88 0.99 (0.97, 1.02) 0.67
SRI- Attendant Symptoms and Sleep (AS) 45 1.01 (0.99, 1.03) 0.20 1.00 (0.98, 1.03) 0.43
SRI- Social Relationships (SR) 45 0.98 (0.96, 1.00) 0.14 0.99 (0.96, 1.01) 0.30
SRI- Anxiety (AX) 45 0.99 (0.98, 1.01) 0.46 0.99 (0.97, 1.01) 0.32
SRI- Psychological Well-Being (WB) 43 0.98 (0.96, 1.00) 0.08 0.97 (0.95, 0.99) 0.03
SRI- Social Functioning (SF) 44 0.96 (0.94, 0.99) 0.002 0.97 (0.94, 0.99) 0.02
Abbreviations: SRI Severe Respiratory Insufficiency, HR hazard ratio, CI confidence interval
a Adjusted for age, daily hours on LTMV and comorbidity
b Numbers do not add to 48 due to missing in the Severe Respiratory Insufficiency questionnaire
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score. This result suggests that LTMV patients with low
SRI should be identified, initiating thorough consider-
ations on how to improve HRQoL. However, whether the
relationship between mortality and quality of life is causal
and changes in HRQoL status in some way influences
mortality cannot be confirmed in this study design.
The minimal clinically important difference of the SRI
questionnaire has not been defined [41]. However, the
great numerical difference in SRI score at baseline
between the surviving LTMV patients and those who
died during the follow-up, support the clinical relevance
of the study.
Strengths and limitations
As far as we are aware, this study is among the very first
to examine SRI scores as a predictor for mortality in
LTMV patients with a follow-up time as long as 80
months. The strengths of the study include the use ofTable 6 Hazard ratios for mortality by baseline scores (both sum sco




SRI- Sum Score (SS) 23 0.98 (0
SRI- Physical Functioning (PF) 23 0.98 (0
SRI- Respiratory Complaints (RC) 23 0.98 (0
SRI- Attendant Symptoms and Sleep (AS) 23 0.98 (0
SRI- Social Relationships (SR) 23 0.99 (0
SRI- Anxiety (AX) 23 0.99 (0
SRI- Psychological Well-Being (WB) 23 0.98 (0
SRI- Social Functioning (SF) 23 0.99 (0
Abbreviations: SRI Severe Respiratory Insufficiency, HR hazard ratio, CI confidence in
a Adjusted for age and comorbidity
b Numbers do not add to 24 due to missing in the Severe Respiratory Insufficiencystandardized data collection [32–34], including relevant
confounders, such as comorbidity, which is often lacking
in study of this type, and the prospective study design.
Another strength is the use of the specific and validated
SRI questionnaire, which can capture HRQoL related to
symptoms and the experience of having CHRF and
LTMV [2, 28–30, 34–43].
The study has some limitations. First, its small sample
size may decrease the statistical power to detect clinic-
ally relevant associations in multivariate Cox analyses.
Second, comorbidity modeled simply as the number of
somatic diagnoses. Charlson Comorbidity Index [54] is a
common index to measure comorbidity using ICD-10
codes. However, as complete ICD-10 codes were not
available in our data, we chose to measure comorbidity
as the number of somatic diagnoses. Thirdly, some of
the LTMV patients answered that they received help to
complete the questionnaire, which might introduce
some information bias in SRI scores. However, it is ofre and sub-scales) of the Severe Respiratory Insufficiency
24) treated with long-term mechanical ventilation between
Adjusteda
% CI P value HR 95% CI P value
.95, 1.01) 0.14 0.97 (0.95, 1.01) 0.19
.95, 1.01) 0.16 0.97 (0.93, 1.01) 0.13
.95, 1.01) 0.33 0.98 (0.95, 1.01) 0.26
.96, 1.01) 0.15 0.97 (0.95, 1.00) 0.10
.97, 1.01) 0.08 0.98 (0.99, 1.01) 0.37
.97, 1.01) 0.32 0.99 (0.97 1.01) 0.34
.96, 1.00) 0.07 0.98 (0.96, 1.00) 0.13
.97, 1.01) 0.50 0.99 (0.97, 1.01) 0.64
terval
questionnaire
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who needed help to fill out the questionnaire.
In addition, because of the observational study design,
we cannot exclude the possibility of residual or unknown
confounding. Whether HRQoL score reflects a percep-
tion by the LTMV patient of progression of her or his
condition or whether change in HRQoL status in some
way also influences the course of the condition is an in-
teresting question. However, the research design cannot
confirm causality between improvement in HRQoL and
survival in this study. To address this question a ran-
domized interventional study aiming to improve HRQoL
with a control group receiving standard treatment would
be more suitable.Conclusion
This study suggests that SRI is an important factor in prog-
nostic mortality models in LTMV-treated patients. The de-
sign and data do not allow us to imply any causal
relationships between a change in HRQoL and a change in
mortality. We propose an active use of the SRI question-
naire in the daily clinic with repeated measurements as part
of individual follow-up. Future studies on this topic should
be larger and preferably organized as multicentre long-term
RCTs, including specific interventions aimed at improving
HRQoL in LTMV patients, compared to standard care.
Even if there is no comparison in this paper made between
SRI and other quality of life measures, we suggest SRI to be
used as the quality of life measure in the studies to come.Additional file
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